Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comis

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1979
Selective surgical resection in small cell carcinoma of the lungJ A Meyer, R L Comis, S J Ginsberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancerF P Lacreta, J M Brennan, S L Nash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferonR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Clinical Immunology and Immunopathology|April 1, 1985
Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's diseaseK W Zamkoff, W G Reeves, F P Paolozzi, et al.
Cancer|September 18, 1998
Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumorsA Kovatich, D M Friedland, T Druck, et al.
Investigational New Drugs|May 1, 1990
Phase I trial of tallysomycin S10b, a bleomycin analogueF P Paolozzi, R C Gaver, N B Newman, et al.
Gynecologic Oncology|December 1, 1991
Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinomaC J Langer, S Nash, R Catalano, et al.
American Journal of Clinical Oncology|August 1, 1989
Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancerJ M Granfortuna, N Newman, S J Ginsberg, et al.
Investigational New Drugs|September 1, 1988
Phase I--preliminary phase II trial of iproplatin, a cisplatin analogueF P Paolozzi, R Gaver, B J Poiesz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot studyA C Wolff, D S Ettinger, D Neuberg, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1979
Selective surgical resection in small cell carcinoma of the lungJ A Meyer, R L Comis, S J Ginsberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancerF P Lacreta, J M Brennan, S L Nash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferonR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Clinical Immunology and Immunopathology|April 1, 1985
Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's diseaseK W Zamkoff, W G Reeves, F P Paolozzi, et al.
Cancer|September 18, 1998
Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumorsA Kovatich, D M Friedland, T Druck, et al.
Investigational New Drugs|May 1, 1990
Phase I trial of tallysomycin S10b, a bleomycin analogueF P Paolozzi, R C Gaver, N B Newman, et al.
Gynecologic Oncology|December 1, 1991
Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinomaC J Langer, S Nash, R Catalano, et al.
American Journal of Clinical Oncology|August 1, 1989
Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancerJ M Granfortuna, N Newman, S J Ginsberg, et al.
Investigational New Drugs|September 1, 1988
Phase I--preliminary phase II trial of iproplatin, a cisplatin analogueF P Paolozzi, R Gaver, B J Poiesz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot studyA C Wolff, D S Ettinger, D Neuberg, et al.
Pageof 12